Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts.
about
Psoriasis: new comorbiditiesEfficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phasQualifying unmet needs and improving standards of care in psoriatic arthritis.Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.Increased risk for chronic comorbid disorders in patients with inflammatory arthritis: a population based study.Cardiovascular risk in patients with psoriatic arthritis.Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis.Diagnosing and treating psoriatic arthritis: an update.Rationale and Design of the Brigham Cohort for psoriasis and psoriatic arthritis registry (COPPAR)Prognostic factors for change in self-reported anxiety and depression in spondyloarthritis patients: data from the population-based SpAScania cohort from southern Sweden.Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain.Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis.Sociodemographic and disease-related factors are associated with patient-reported anxiety and depression in spondyloarthritis patients in the Swedish SpAScania cohort.Prevalence of cardiovascular risk factors in patients with psoriatic arthritis.Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life.Autoimmune Arthritides, Rheumatoid Arthritis, Psoriatic Arthritis, or Peripheral Spondyloarthritis Following Lyme Disease.A clinically based protein discovery strategy to identify potential biomarkers of response to anti-TNF-α treatment of psoriatic arthritis.
P2860
Q28073922-2A624BE2-0636-4312-9EAF-97D45BA339C3Q33659249-2981D3A6-69AF-42A2-9C5D-C2187C3BCCE9Q34803582-55BA6F1A-D00C-4FEB-8DE5-B85ABFCFC731Q34812877-04BA4C67-7870-48EE-9062-E5F58B983A3DQ35074573-B1909684-DD02-4873-892A-341836332C42Q35974962-BBACA505-1252-4656-8B76-F29A694B1DC5Q38114903-490C9807-9D81-42C6-BE80-0F6379CCC782Q38165235-AF256BF5-253B-47BE-B404-75318C420B50Q38621658-8D8C3BE0-E078-4037-964C-F744084B30C8Q38622512-E7020A4E-48F9-4FFE-952C-898B767DA12AQ39227956-51393A71-8109-4FA1-8F36-1F6DA8CE27CCQ46337002-A6FE4F1E-1E98-4DD2-9F36-C6B99165ABCAQ47864935-C2E534A2-768F-4062-A9D3-F4AFE84A24EDQ48252795-7A1FD234-B7A5-4E6A-8C9A-8F4233F90A92Q48446936-5FFC19EE-EDA3-4378-A562-69F014BB9F77Q50317575-2B3C6A5E-D81E-4766-B2E4-712B9B0E8D03Q50960278-29A82129-D926-4A23-88F6-507A9F257E41
P2860
Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Prevalence of patient-reported ...... d psoriatic arthritis cohorts.
@en
Prevalence of patient-reported ...... d psoriatic arthritis cohorts.
@nl
type
label
Prevalence of patient-reported ...... d psoriatic arthritis cohorts.
@en
Prevalence of patient-reported ...... d psoriatic arthritis cohorts.
@nl
prefLabel
Prevalence of patient-reported ...... d psoriatic arthritis cohorts.
@en
Prevalence of patient-reported ...... d psoriatic arthritis cohorts.
@nl
P2093
P2860
P1476
Prevalence of patient-reported ...... d psoriatic arthritis cohorts.
@en
P2093
Don MacDonald
Emmanouil Rampakakis
John S Sampalis
Julie Vaillancourt
Majed Khraishi
P2860
P304
P356
10.1007/S10067-011-1692-7
P577
2011-02-02T00:00:00Z